Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Mako Medical Laboratories Focuses on New Program Targeted at Helping Seniors


RALEIGH, N.C., Feb. 10, 2020 /PRNewswire/ -- The fastest-growing population in America are the baby boomers. Currently, 14.5% of the nation's population is age 65+.

By the year 2029, the national population of those age 65+ will be 20%. The federal government passed the Protecting Access to Medicare Act of 2014 (PAMA) which required significant changes to how Medicare pays for clinical diagnostic laboratory tests under the Clinical Laboratory Fee Schedule (CLFS). The financial impact for clinical laboratories began in 2016 with annual cuts of 10% for the first three years and 15% for the next three years. 

Due to the drastic multi-year cuts to Medicare rates, senior care facilities' access to timely testing is severely jeopardized. This will lead to a void in the marketplace as many providers shift their focus away from skilled nursing and assisted living facilities. 

Mako Medical Laboratories has launched an effort to make sure no senior is left behind. Mako Medical Laboratories has built statewide logistics and mobile phlebotomy teams to fill the void created by PAMA cuts. Nolan McBride, Mako Medical Laboratories Senior Care Executive, stated, "Mako Medical goes where others are not willing to go. We service all patients and we will not let our senior care communities suffer due to reimbursement and regulatory changes. We have especially made a focus to build coverage in the rural markets." McBride's passion for filling the gaps of healthcare come from a long family history of medical providers. His grandfather served the rural communities of North Carolina and South Carolina. "Healthcare and service are in my blood. We at Mako Medical just want to serve and fill those gaps."

Filling those gaps is just one piece of the puzzle. Getting the patient specimens from rural communities back to the Mako Medical laboratories, then timely running those patient specimens and returning a result same day is an entirely additive level of complexity. Steve Hoover, Mako Medical Laboratories Vice President of Laboratory Operations, said "Many of the senior care patients have critical results that require immediate turnaround times. Our job is to make sure the results get back immediately so the medical providers can treat those patients. The absolute last thing we want is for a patient to end up in the hospital due to subpar laboratory services." Hoover continued to explain the in-depth nature of the senior care laboratory space. With over 20 years of experience, he has seen a lot. "It amazes me how these patients are left with substandard care in America. When I joined Mako Medical, I knew we had to fill this gap. With our technology, logistics and phlebotomy infrastructure, and executive focus, we are completely changing the way laboratory medicine is given to our seniors." 

Mako Medical Laboratories currently is expanding throughout the Southeast with a full network of mobile phlebotomists and logistics couriers to prepare for the needs of these patients.

Mako Medical Laboratories is a full-service reference laboratory with full-scale logistics, laboratory, pharmacy, and phlebotomy operations. Mako Medical is known for its extensive community service and for hiring military veterans.  

Contact: [email protected]

Related Images

image1.jpeg
image2.jpeg
image3.jpeg

Related Links

Mako Medical

Mako DNA

SOURCE Mako Medical Laboratories


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: